Semaglutide: The Science Behind the Weight Loss At Rivas Medical Weight Loss, we proudly offer Semaglutide, an FDA-approved medication that has significantly impacted the treatment of obesity
Endogenous GLP-1 has several functions, including triggering insulin release from the pancreas, as well as decreasing appetite and digestion, and this drug class mimics the GLP-1 hormone
Nature 546 , 259264 (2017)
Originally developed to help people with type 2 diabetes, they are now also prescribed for obesity and weight management
The negative attitude of Novo Nordisk was summed up by Lars Srenson, the company's CEO, who in 2005 argued 'Obesity is primarily a social and cultural problem
"A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1)"